Abstract Polyendocrine metabolic ovarian syndrome (PMOS), previously known as polycystic ovary syndrome, affects 10%–13% of women of reproductive age and remains underdiagnosed despite its substantial health burden. The introduction of the new PMOS nomenclature in 2026 reflects a fundamental shift in understanding the condition as a lifelong endocrine ...
Maria Forslund +5 more
wiley +1 more source
Association between central thyroid hormone dysregulation and chronic kidney disease in type 2 diabetes: a cross-sectional study. [PDF]
Huang H +8 more
europepmc +1 more source
Endocrine-Metabolic Crosstalk Between Diabetes Mellitus and Hypothyroidism: From Network Mechanisms to Translational Stratification. [PDF]
Yang X +10 more
europepmc +1 more source
Can Thyroid Dysfunction Contribute to Infertility via Lipid Abnormalities? [PDF]
Kelly RB +4 more
europepmc +1 more source
Long-term TSH suppression in metabolically unhealthy survivors of differentiated thyroid cancer: a cardiovascular perspective. [PDF]
Chai J +5 more
europepmc +1 more source
Polyendocrine metabolic ovarian syndrome in adolescents. [PDF]
Furness A, McQuillan S.
europepmc +1 more source
Evaluation of serum soluble triggering receptor expressed on myeloid cells-1 in polycystic ovary syndrome. [PDF]
Onat T +6 more
europepmc +1 more source
Clinical factors associated with recurrent pregnancy loss status in women with polyendocrine metabolic ovarian syndrome. [PDF]
Sheng C +4 more
europepmc +1 more source
Integrative Network View of PCOS: Organ Crosstalk Driven by the Hyperandrogenemia-Insulin Resistance-Inflammation Triad. [PDF]
Luo Z +9 more
europepmc +1 more source

